Evidence map›Paper›PMID 36907734›Full record

ArticleVaccine2023

Prevalence of influenza-specific vaccination hesitancy among adults in the United States, 2018.

Anup Srivastav, Peng-Jun Lu, Ashley Amaya, Jill A Dever, Marshica Stanley, Jessica L Franks, Paul J Scanlon, Allison M Fisher, Stacie M Greby, Kimberly H Nguyen and 1 more

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Perceptions About Influenza and COVID-19 Vaccines Among People With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Anup SrivastavLeidos Incorporated, Atlanta, GA, USA; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: xbs2@cdc.gov.
Peng-Jun LuImmunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lhp8@cdc.gov.
Ashley AmayaPew Research, District of Columbia, WA, USA. Electronic address: aamaya@pewresearch.org.
Jill A DeverRTI International, District of Columbia, WA, USA. Electronic address: jdever@rti.org.
Marshica StanleyRTI International, Research Triangle Park, NC, USA. Electronic address: mstanley@rti.org.
Jessica L FranksRTI International, Research Triangle Park, NC, USA. Electronic address: jroycroft@rti.org.
Paul J ScanlonDivision of Research and Methodology, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD, USA. Electronic address: wyv6@cdc.org.
Allison M FisherOffice of Health Communications, Office of the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: ark2@cdc.gov.
Stacie M GrebyDivision of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: sig6@cdc.gov.
Kimberly H NguyenImmunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: kimberly.nguyen@fda.hhs.gov.
Carla L BlackImmunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: zwc0@cdc.gov.
National Center for Immunization and Respiratory Diseases · USRTI International · USCenters for Disease Control and Prevention · USCenter for Global Health · USLeidos (United States) · USPew Research Center · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundThe role of vaccine hesitancy on influenza vaccination is not clearly understood. Low influenza vaccination coverage in U.S. adults suggests that a multitude of factors may be responsible for under-vaccination or non-vaccination including vaccine hesitancy. Understanding the role of influenza vaccination hesitancy is important for targeted messaging and intervention to increase influenza vaccine confidence and uptake. The objective of this study was to quantify the prevalence of adult influenza vaccination hesitancy (IVH) and examine association of IVH beliefs with sociodemographic factors and early-season influenza vaccination.

methodsA four-question validated IVH module was included in the 2018 National Internet Flu Survey. Weighted proportions and multivariable logistic regression models were used to identify correlates of IVH beliefs.

resultsOverall, 36.9% of adults were hesitant to receive an influenza vaccination; 18.6% expressed concerns about vaccination side effects; 14.8% personally knew someone with serious side effects; and 35.6% reported that their healthcare provider was not the most trusted source of information about influenza vaccinations. Influenza vaccination ranged from 15.3 to 45.2 percentage points lower among adults self-reporting any of the four IVH beliefs. Being female, age 18-49 years, non-Hispanic Black, having high school or lower education, being employed, and not having primary care medical home were associated with hesitancy.

conclusionsAmong the four IVH beliefs studied, being hesitant to receiving influenza vaccination followed by mistrust of healthcare providers were identified as the most influential hesitancy beliefs. Two in five adults in the United States were hesitant to receive an influenza vaccination, and hesitancy was negatively associated with vaccination. This information may assist with targeted interventions, personalized to the individual, to reduce hesitancy and thus improve influenza vaccination acceptance.

Indexed as

Influenza, HumanInfluenza VaccinesAdolescentAdultFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPrevalenceUnited StatesVaccinationVaccination HesitancyYoung AdultInfluenza VaccinesInfluenza vaccinationInfluenza vaccination hesitancyVaccination acceptance

Identifiers

PMID36907734
PMCPMC10941755
OpenAlexW4323838846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.